SCHEDULE: Ronen Fatal Discloses 8.76% Stake in SciSparc Ltd.
Beneficial Ownership Disclosure
Ronen Fatal has disclosed a beneficial ownership of 8.76% in SciSparc Ltd., holding 287,267 ordinary shares.
Summary
- Ronen Fatal reported beneficial ownership of 287,267 ordinary shares of SciSparc Ltd.
- This ownership represents 8.76% of SciSparc Ltd.'s outstanding ordinary shares.
- The percentage is calculated based on 3,276,378 ordinary shares issued and outstanding, as reported by SciSparc Ltd. in a prospectus supplement filed on November 28, 2025.
- Ronen Fatal holds sole voting power and sole dispositive power over all 287,267 shares.
- The securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The disclosure of a significant beneficial ownership stake by an individual investor is generally a neutral to slightly positive signal, indicating an investor's confidence in the company, though it provides no operational or financial performance details.
Positives
- A significant beneficial ownership stake of 8.76% by an individual investor may signal confidence in SciSparc Ltd.'s future prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by an individual investor, which is a common occurrence in the public markets. It does not provide specific operational or strategic insights into SciSparc Ltd.'s industry position or competitive landscape.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by an individual investor could be interpreted as a vote of confidence, potentially influencing investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/28/2025 | Date of event which requires filing of this statement, and the date SciSparc Ltd. reported 3,276,378 ordinary shares outstanding in a prospectus supplement. |
| 12/11/2025 | Date the Schedule 13G statement was signed by Ronen Fatal. |
Keywords
SciSparc Ltd., Ronen Fatal, Beneficial Ownership, Schedule 13G, Ordinary Shares, Equity Stake, Investor Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.